Archives for March 16, 2005

← 2005

GPC shores up kinase portfolio with Axxima buy

German cancer drug company GPC Biotech has agreed to buy the material assets of Munich-based kinase specialist Axxima Pharmaceuticals in a cash-neutral transaction for €13.7m.

New clients for HTMS firm Biotrove

US company Biotrove says its mass spectrometry-based high-throughput screening (HTS) system, RapidFire Lead Discovery, has been used to screen more than a million individual samples over the last 12 months.

Discovery and development impacts on pharma R&D

R&D productivity is currently in a period of decline, with the number of new medicines being introduced to the market declining in the face of increasing R&D budgets. However, the emergence of genomics-derived drugs is expected to enter the...

FMC raises price of MCC range

Costs rises for raw materials and energy push Philadelphia-based FMC BioPolymer to hike up prices for its cellulose gel range.

MAb purification products launched by GE

GE Healthcare has launched two new products designed to meet growing industry needs for the purification of monoclonal antibodies, one of the fastest growing drug classes in the drug industry.

Roche's Avastin launched in Europe

Roche has started the roll-out its colorectal cancer treatment Avastin (bevacizumab) - the first drug to reach the market that works by inhibiting blood vessel formation in tumours - in Europe.

Discovery could improve transdermal drug delivery

A group of US researchers claim to have identified a fundamental mechanism that may facilitate the design of safer and more efficacious topical drug delivery systems, reports Phil Taylor.